Entering text into the input field will update the search result below

Aytu BioScience EPS misses by $0.28, beats on revenue

Feb. 11, 2021 4:55 PM ETAytu BioPharma, Inc. (AYTU) StockBy: Pranav Ghumatkar, SA News Editor1 Comment
  • Aytu BioScience (NASDAQ:AYTU): FQ2 GAAP EPS of -$0.72 misses by $0.28.
  • Revenue of $15.15M (+376.4% Y/Y) beats by $2.9M.
  • Ended the quarter with $62.3M in cash, equivalents and restricted cash.
  • Announced definitive merger agreement with Neos Therapeutics, creating a combined $100M revenue specialty pharmaceutical company.
  • Shares -5.26%.
  • Press Release

Recommended For You

About AYTU Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
AYTU--
Aytu BioPharma, Inc.